Home
Conditions
Lymphoma, Mantle-Cell

Clinical trial condition

Lymphoma, Mantle-Cell

Explore clinical trials studying Lymphoma, Mantle-Cell. Study availability and eligibility vary by location and protocol.

889 public trials 111 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Mantle-Cell trial results

Completed

Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma

NCT00278421

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +21 more
Locations: Haematologisch Onkologische Praxis Aachen, Germany

Klinikum Augsburg Augsburg, Germany

Klinikum Bayreuth Bayreuth, Germany

Haematologisch-Onkologische Schwerpunktpraxis - Weilheim Berlin, Germany

View all 78 locations

View Trial Details

Completed

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

NCT00489203

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +207 more
Locations: Hackensack University Medical Center Hackensack, New Jersey, United States

Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Safety and Tolerability of HSC835 in Patients With Hematological Malignancies

NCT01474681

Conditions: Acute Lymphocytic Leukemia, Acute Myelocytic Leukemia, Bone Marrow Diseases, +51 more
Locations: Novartis Investigative Site Minneapolis, Minnesota, United States

View Trial Details

Completed

A Study in Healthy Subjects to Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect) of Acalabrutinib Tablet and Protonpump Inhibitor Effect (Members of a Class of Medications That Inhibits in Gastric Acid Production) for Rabeprazole

NCT04564040

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +20 more
Locations: Research Site Berlin, Germany

View Trial Details

Completed

Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

NCT00612716

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Study of Bortezomib (BTZ) Treatment on Mantle Cell Lymphoma (MCL) in Chinese Participants

NCT03053024

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Cancer Hospital, Chinese Academy of Medical Sciences Beijing, China

Peking University Cancer Hospital Beijing, China

The First Hospital of Jilin University Changchun, China

Xiangya Hospital Central South University Changsha, China

View Trial Details

Completed

Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma

NCT01258998

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +82 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Ibrutinib for Relapsed or Refractory Mantle Cell Lymphoma

NCT04061850

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: 81, Irwon-ro, Gangnam-gu, Seoul, Republic of Korea Seoul, South Korea

View Trial Details

Completed

Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma

NCT01075321

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +59 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies

NCT00536978

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +20 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Lymphoma, Mantle-Cell

Lymphoma, Mantle-Cell trial results

Related conditions